Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sirtris Pharmaceuticals
company
About
Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.
- 51 - 100
Highlights
Details
- Last Funding Type
- Debt Financing
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2004
- Number Of Employee
- 51 - 100
- Operating Status
- Active
[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$37M
Sirtris Pharmaceuticals has raised a total of
$37M
in funding over 2 rounds. Their latest funding was raised on
Apr 20, 2006 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2006 | Debt Financing | — | 1 |
Hercules Capital
|
— | Detail |
| Apr 19, 2006 | Series C | $37M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Sirtris Pharmaceuticals is funded by 2 investors.
Hercules Capital
and Hunt Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Debt Financing |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
